Delivery Order SPE2DB24D9144-SPE2DB24FCMJZ

Award Date 8/15/24
Potential Completion Date 9/6/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,742.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. The contract is a delivery order issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $13,024.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive product. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) SPE2DB with DLA, valued at up to $4,999,999 through 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,736.00 firm fixed-price delivery order is for the supply of Mirena 52 mg intrauterine systems, a contraceptive device. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $28,176.50 firm fixed-price delivery order is for the supply of Mirena 52 mg intrauterine systems, a contraceptive device, to support the recurring medical needs of military health facilities. The award is part of a larger $499,999,999 indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at up to $14,208, is for the delivery of Mirena 52 mg intrauterine contraceptive systems. It is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2024. The contract is not associated with any set-aside program. It is part of a larger indefinite delivery/indefinite quantity...
This is a federal contract awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $4,736.00, is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order issued under a larger single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,552.00 firm fixed-price delivery order is for the supply of Mirena 52 mg intrauterine systems, a contraceptive device. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,960.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Mirena 52 mg Systems, a type of intrauterine contraceptive device. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range...
The U.S. government, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract valued at $1,776.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a period of performance through December 12, 2024, is for the provision of Mirena 52 mg systems, a type of intrauterine contraceptive device. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,648.60 firm fixed-price delivery order contract is for the supply of Mirena 52 mg intrauterine systems, a hormonal contraceptive. This award is a task order under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA. The IDC enables the DLA to...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMJZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $4,736.00, is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive device.

The contract is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. As a woman-owned small business, DMS Pharmaceutical Group leverages its status to secure direct awards for pharmaceutical Prime Vendor programs supporting the Department of Defense healthcare system.

Generated 11/14/24, 9:14 AM